Personalized cancer treatment shows promise for elderly patients
NCT ID NCT04151667
Summary
This study is testing a flexible treatment strategy for older adults with newly diagnosed multiple myeloma, a blood cancer. Patients first receive a two-drug combination, and doctors then adjust their treatment based on how well they respond. The goal is to control the disease effectively while potentially reducing side effects for patients who may not tolerate more aggressive treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer & Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.